MCID: NRT001
MIFTS: 53

Neurotic Disorder

Categories: Mental diseases, Neuronal diseases

Aliases & Classifications for Neurotic Disorder

MalaCards integrated aliases for Neurotic Disorder:

Name: Neurotic Disorder 12 15 17
Adjustment Disorders 43 71 32
Neurosis 12 36 15
Reactive Depression 12 71
Neurotic Disorders 43 71
Neurotic Depression Reactive Type 12
Neurotic Depressive State 12
Depression, Neurotic 71
Depressive Neurosis 12
Neurotic Depression 12
Depressive Disorder 71
Psychoneurosis 12

Classifications:



External Ids:

Disease Ontology 12 DOID:4964
KEGG 36 H01671
SNOMED-CT 67 111475002 87414006
UMLS 71 C0001546 C0011579 C0011581 more

Summaries for Neurotic Disorder

KEGG : 36 Neurosis is a class of functional mental disorders involving distress but neither delusions nor hallucinations, whereby behavior is not outside socially acceptable norms. The state of research on neurosis has moved towards looking at biological and genetic substrates or mechanisms underlying neurosis. The recent literature shows acceptance of common mental disorders such as Generalized anxiety disorder (GAD), Panic disorder (PD), and Obsessive-compulsive disorder (OCD), across cultures replacing neurotic disorder. Usage of the diagnosis of neurosis has been decreased, and replaced by newer categories in the current popular classificatory systems. In the International Classification of Diseases (ICD-10), all disorders regarded as neurosis remained together but under the division of rubric 'neurotic, stress-related and somatoform disorders'. In the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), neurosis has been eliminated as a category.

MalaCards based summary : Neurotic Disorder, also known as adjustment disorders, is related to somatization disorder and obsessive-compulsive personality disorder, and has symptoms including depressed reaction and depressed - symptom. An important gene associated with Neurotic Disorder is MFSD8 (Major Facilitator Superfamily Domain Containing 8), and among its related pathways/superpathways are Neuroactive ligand-receptor interaction and Dopaminergic synapse. The drugs Valsartan and Ropinirole have been mentioned in the context of this disorder. Affiliated tissues include brain, testes and heart, and related phenotypes are behavior/neurological and cardiovascular system

Disease Ontology : 12 An anxiety disorder that involves discress but neither delusions nor hallucinations.

Wikipedia : 74 Neurosis is a class of functional mental disorders involving chronic distress but neither delusions nor... more...

Related Diseases for Neurotic Disorder

Diseases related to Neurotic Disorder via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 292, show less)
# Related Disease Score Top Affiliating Genes
1 somatization disorder 30.3 SLC6A4 HTR2A FLNA
2 obsessive-compulsive personality disorder 30.3 SLC6A4 HTR2A
3 body dysmorphic disorder 30.2 SLC6A4 MAOA HTR2A
4 dissociative disorder 30.1 SLC6A4 HTR2A BDNF
5 delusional disorder 29.9 TH HTR2A HTR1A
6 tic disorder 29.7 SLC6A4 MAOA HTR2A HTR1A
7 antisocial personality disorder 29.5 SLC6A4 MAOA HTR2A
8 dysthymic disorder 29.5 SLC6A4 MAOA HTR2A HTR1A BDNF
9 panic disorder 29.5 SLC6A4 MAOA HTR2A HTR1A BDNF
10 eating disorder 29.5 SLC6A4 HTR2A BDNF
11 diarrhea 29.5 TNF SLC6A4 HTR1A FLNA
12 hypochondriasis 29.4 SLC6A4 HTR2A HTR1A BDNF
13 social phobia 29.3 SLC6A4 MAOA HTR1A BDNF
14 generalized anxiety disorder 29.2 SLC6A4 MAOA HTR2A HTR1A BDNF
15 somatoform disorder 29.2 TNF SLC6A4 BDNF
16 personality disorder 29.2 TH SLC6A4 MAOA HTR2A HTR1A BDNF
17 alcohol use disorder 29.2 SLC6A4 HTR2A HTR1A BDNF
18 adjustment disorder 29.1 SLC6A4 HTR2A HTR1A FLNA BDNF
19 depression 29.0 SLC6A4 MAOA HTR2A HTR1A BDNF
20 post-traumatic stress disorder 29.0 SLC6A4 MAOA HTR2A HTR1A BDNF
21 chronic fatigue syndrome 29.0 TNF SLC6A4 MAOA HTR2A HTR1A
22 substance abuse 29.0 SLC6A4 MAOA HTR2A HTR1A BDNF
23 atypical depressive disorder 28.9 SLC6A4 MAOA HTR2A HTR1A BDNF
24 schizoaffective disorder 28.8 SLC6A4 HTR2A HTR1A BDNF
25 agoraphobia 28.8 SLC6A4 MAOA HTR2A HTR1A BDNF
26 anorexia nervosa 28.8 SLC6A4 MAOA HTR2A HTR1A BDNF
27 obsessive-compulsive disorder 28.5 TNF SLC6A4 MAOA HTR2A HTR1A BDNF
28 borderline personality disorder 28.5 TH SLC6A4 MAOA HTR2A HTR1A BDNF
29 migraine with or without aura 1 28.5 TNF SLC6A4 MAOA HTR2A HTR1A BDNF
30 mood disorder 28.3 TH SLC6A4 MAOA HTR2A HTR1A BDNF
31 psychotic disorder 28.3 TH SLC6A4 MAOA HTR2A HTR1A BDNF
32 endogenous depression 28.3 TH SLC6A4 MAOA HTR2A HTR1A BDNF
33 narcolepsy 28.3 TNF SLC6A4 MAOA HTR2A BDNF
34 fibromyalgia 28.2 TNF SLC6A4 HTR2A HTR1A BDNF
35 alcohol dependence 28.2 TNF TH SLC6A4 MAOA HTR2A HTR1A
36 major depressive disorder 28.2 TNF SLC6A4 MAOA HTR2A HTR1A BDNF
37 paranoid schizophrenia 28.1 TNF SLC6A4 MAOA HTR2A HTR1A BDNF
38 mental depression 28.1 TNF SLC6A4 MAOA HTR2A HTR1A BDNF
39 dementia 28.1 TNF TH MFSD8 HTR2A HTR1A BDNF
40 anxiety 27.9 TNF TH SLC6A4 MAOA HTR2A HTR1A
41 sleep disorder 27.9 TNF TH SLC6A4 HTR2A HTR1A BDNF
42 schizophrenia 27.8 TNF TH SLC6A4 MAOA HTR2A HTR1A
43 melancholia 27.7 TNF SLC6A4 SEMA3F-AS1 MAOA HTR2A HTR1A
44 disease of mental health 27.6 TNF TH SLC6A4 MAOA HTR2A HTR1A
45 bipolar disorder 27.5 TNF TH SLC6A4 MAOA HTR2A HTR1A
46 autism 27.5 TNF TH SLC6A4 MAOA HTR2A HTR1A
47 panic disorder 1 11.7
48 conversion disorder 11.7
49 orthostatic intolerance 11.5
50 wilson disease 11.3
51 combat disorder 11.2
52 giant axonal neuropathy 2 10.5 GAN DCAF8
53 narcissistic personality disorder 10.4 MFSD8 FLNA
54 paranoid personality disorder 10.4 MFSD8 FLNA
55 parametritis 10.4 LY96 LY86
56 intestinal botulism 10.4 LY96 FBXW2
57 myopathy, myofibrillar, 6 10.4 GAN DCAF8
58 inhibited male orgasm 10.4 SLC6A4 HTR1A
59 wound botulism 10.4 LY96 FBXW2
60 drug psychosis 10.4 HTR2A HTR1A
61 frontometaphyseal dysplasia 1 10.4 FLNA FBXW2
62 drug-induced mental disorder 10.4 HTR2A HTR1A
63 head injury 10.3
64 avoidant personality disorder 10.3
65 alcoholic psychosis 10.3 SLC6A4 HTR2A
66 acute laryngopharyngitis 10.3 LY96 LY86 FBXW2
67 substance-induced psychosis 10.2 HTR2A HTR1A
68 alcoholic neuropathy 10.2 NAA50 MAOA
69 hyperthyroidism 10.2
70 bruxism 10.2 SLC6A4 HTR2A HTR1A
71 duodenal ulcer 10.2
72 kleptomania 10.2 SLC6A4 MAOA HTR1A
73 hemoglobin d disease 10.2 LY86 GPX4
74 depersonalization disorder 10.1
75 phobia, specific 10.1 SLC6A4 MAOA HTR1A
76 asthma 10.1
77 diabetes mellitus 10.1
78 diabetes insipidus 10.1
79 voyeurism 10.1 SEMA3F-AS1 MAOA
80 brunner syndrome 10.1 SLC6A4 MAOA HTR2A
81 hypoactive sexual desire disorder 10.1 SEMA3F-AS1 HTR2A HTR1A
82 mononeuritis of upper limb and mononeuritis multiplex 10.1 TNF DCAF8
83 exhibitionism 10.1 SEMA3F-AS1 MAOA
84 spinal arachnoiditis 10.1
85 body mass index quantitative trait locus 11 10.1
86 body mass index quantitative trait locus 9 10.1
87 body mass index quantitative trait locus 8 10.1
88 hypertension, early-onset, autosomal dominant, with severe exacerbation in pregnancy 10.1
89 body mass index quantitative trait locus 4 10.1
90 body mass index quantitative trait locus 10 10.1
91 body mass index quantitative trait locus 7 10.1
92 body mass index quantitative trait locus 12 10.1
93 body mass index quantitative trait locus 14 10.1
94 body mass index quantitative trait locus 18 10.1
95 body mass index quantitative trait locus 19 10.1
96 gastrointestinal ulceration, recurrent, with dysfunctional platelets 10.1
97 body mass index quantitative trait locus 20 10.1
98 angina pectoris 10.1
99 amnestic disorder 10.1
100 heart disease 10.1
101 arachnoiditis 10.1
102 epilepsy 10.1
103 peptic ulcer disease 10.1
104 hypoglycemia 10.1
105 47,xyy 10.1
106 pedophilia 10.0 SEMA3F-AS1 MFSD8 MAOA
107 inflammatory and toxic neuropathy 10.0 TNF NAA50
108 migraine with aura 10.0 SLC6A4 HTR2A FLNA
109 raynaud disease 10.0
110 yemenite deaf-blind hypopigmentation syndrome 10.0
111 suppression amblyopia 10.0
112 amblyopia 10.0
113 mastitis 10.0
114 pellagra 10.0
115 raynaud phenomenon 10.0
116 headache 10.0
117 leprosy 3 10.0 TNF FLNA DCAF8
118 acute stress disorder 10.0
119 autonomic dysfunction 10.0
120 intermittent explosive disorder 10.0 SLC6A4 MAOA HTR2A HTR1A
121 serotonin syndrome 10.0 SLC6A4 MAOA HTR2A HTR1A
122 hypertension, essential 10.0
123 mitral valve prolapse 1 10.0
124 graves disease 1 10.0
125 trichotillomania 10.0
126 rheumatic heart disease 10.0
127 oculogyric crisis 10.0
128 sexual sadism 10.0
129 fetishism 10.0
130 gout 10.0
131 hypothyroidism 10.0
132 factitious disorder 10.0
133 pharyngitis 10.0
134 arteriosclerosis 10.0
135 biliary dyskinesia 10.0
136 bronchopulmonary dysplasia 10.0
137 fibromatosis 10.0
138 cerebral hypoxia 10.0
139 hypoxia 10.0
140 tremor 10.0
141 whiplash 10.0
142 impulse control disorder 10.0 SLC6A4 MAOA HTR2A HTR1A
143 pathological gambling 10.0 SLC6A4 MAOA HTR2A HTR1A
144 macular dystrophy with central cone involvement 9.9
145 mitral valve stenosis 9.9
146 insensitivity to pain, congenital, with anhidrosis 9.9 NAA50 BDNF
147 migraine without aura 9.9 TNF SLC6A4 HTR1A
148 vascular dementia 9.9
149 binswanger's disease 9.9
150 hypersomnia 9.9
151 persistent idiopathic facial pain 9.9
152 paraphilia disorder 9.9 SEMA3F-AS1 MAOA
153 severe combined immunodeficiency 9.9
154 psychosexual disorder 9.9 SLC6A4 SEMA3F-AS1 HTR2A HTR1A
155 sexual disorder 9.9 SLC6A4 SEMA3F-AS1 HTR2A HTR1A
156 bilateral acute depigmentation of the iris 9.8
157 hair whorl 9.8
158 rheumatoid arthritis 9.8
159 triiodothyronine receptor auxiliary protein 9.8
160 dermatitis, atopic 9.8
161 major affective disorder 8 9.8
162 major affective disorder 9 9.8
163 stuttering 9.8
164 physical disorder 9.8
165 rheumatic fever 9.8
166 impotence 9.8
167 opiate dependence 9.8
168 dermatitis 9.8
169 arthropathy 9.8
170 pustulosis of palm and sole 9.8
171 dystonia 9.8
172 psoriasis 9.8
173 neonatal hypoxic and ischemic brain injury 9.8 TH BDNF
174 anisocoria 9.8
175 arteries, anomalies of 9.8
176 hepatocellular carcinoma 9.8
177 pilomatrixoma 9.8
178 hand skill, relative 9.8
179 pheochromocytoma 9.8
180 torticollis 9.8
181 varicose veins 9.8
182 adrenoleukodystrophy 9.8
183 arts syndrome 9.8
184 paine syndrome 9.8
185 aging 9.8
186 helicobacter pylori infection 9.8
187 schizophrenia 3 9.8
188 stroke, ischemic 9.8
189 coronary heart disease 1 9.8
190 intraocular pressure quantitative trait locus 9.8
191 hyperprolactinemia 9.8
192 striatal degeneration, autosomal dominant 2 9.8
193 chorea, childhood-onset, with psychomotor retardation 9.8
194 hyperlipoproteinemia, type iii 9.8
195 lipoprotein quantitative trait locus 9.8
196 hypophosphatemia 9.8
197 cervical dystonia 9.8
198 adrenal gland pheochromocytoma 9.8
199 aphasia 9.8
200 nosophobia 9.8
201 colitis 9.8
202 ileitis 9.8
203 crohn's colitis 9.8
204 spinal disease 9.8
205 gastric ulcer 9.8
206 sexual masochism 9.8
207 brucellosis 9.8
208 miliaria rubra 9.8
209 esophagitis 9.8
210 goiter 9.8
211 choreatic disease 9.8
212 conduct disorder 9.8
213 miliaria 9.8
214 facial neuralgia 9.8
215 peptic esophagitis 9.8
216 vascular disease 9.8
217 neuroma 9.8
218 enthesopathy 9.8
219 pulmonary tuberculosis 9.8
220 shwartzman phenomenon 9.8
221 thrombophlebitis 9.8
222 gastritis 9.8
223 systemic scleroderma 9.8
224 nominal aphasia 9.8
225 essential tremor 9.8
226 thyroid gland disease 9.8
227 pneumonia 9.8
228 paraplegia 9.8
229 premenstrual tension 9.8
230 gastrointestinal system disease 9.8
231 myocarditis 9.8
232 cyclothymic disorder 9.8
233 arthritis 9.8
234 hodgkin's lymphoma, lymphocytic-histiocytic predominance 9.8
235 ulcerative colitis 9.8
236 scarlet fever 9.8
237 subacute delirium 9.8
238 neurofibromatosis 9.8
239 crohn's disease 9.8
240 pulmonary embolism 9.8
241 encephalitis 9.8
242 adrenomyeloneuropathy 9.8
243 koro 9.8
244 brain injury 9.8
245 fainting 9.8
246 cranial neuralgia 9.8
247 acute radiation syndrome 9.8
248 retrograde amnesia 9.8 SLC6A4 HTR1A BDNF
249 alexithymia 9.8
250 heroin dependence 9.7 SLC6A4 MAOA BDNF
251 childhood disintegrative disease 9.6 MFSD8 BDNF
252 major affective disorder 1 9.6
253 femoral neuropathy 9.6
254 lung disease 9.6
255 neuropathy 9.6
256 muscular dystrophy 9.6
257 chronic pain 9.6
258 central hypoventilation syndrome, congenital 9.6 TH HTR1A BDNF
259 bipolar i disorder 9.6 SLC6A4 HTR2A HTR1A BDNF
260 pulmonary hypertension, primary, 1 9.6
261 leukemia, acute myeloid 9.6
262 macular degeneration, age-related, 1 9.6
263 leukemia, acute lymphoblastic 9.6
264 female breast cancer 9.6
265 withdrawal disorder 9.6
266 covid-19 9.6
267 acute myocardial infarction 9.6
268 spinal cord injury 9.6
269 ileocolitis 9.6 TNF GPX4
270 tendinosis 9.6 TH BDNF
271 postpartum depression 9.5 SLC6A4 MAOA HTR1A BDNF
272 substance dependence 9.5 SLC6A4 MAOA BDNF
273 asperger syndrome 9.5 SLC6A4 ERICD BDNF
274 bulimia nervosa 9.5 SLC6A4 MAOA HTR2A BDNF
275 tobacco addiction 9.5 SLC6A4 MAOA HTR2A BDNF
276 phobic disorder 9.4 SLC6A4 MAOA HTR2A HTR1A BDNF
277 ectodermal dysplasia 10b, hypohidrotic/hair/tooth type, autosomal recessive 9.4 TNF TH BDNF
278 toxic encephalopathy 9.3 TNF TH BDNF
279 specific developmental disorder 9.3 SLC6A4 MAOA HTR2A HTR1A BDNF
280 kagami-ogata syndrome 9.3 TNF SLC6A4 BDNF
281 motor neuron disease 9.3 TNF HTR2A HTR1A BDNF
282 sleep apnea 9.3 TNF SLC6A4 HTR2A BDNF
283 central nervous system disease 9.2 TNF SLC6A4 HTR2A BDNF
284 peripheral nervous system disease 9.2 TNF NAA50 GAN DCAF8 BDNF
285 irritable bowel syndrome 9.2 TNF SLC6A4 HTR2A HTR1A BDNF
286 gilles de la tourette syndrome 9.0 TH SLC6A4 MAOA HTR2A HTR1A BDNF
287 attention deficit-hyperactivity disorder 9.0 TH SLC6A4 MAOA HTR2A HTR1A BDNF
288 parkinson disease, late-onset 8.9 TH SLC6A4 MAOA HTR2A HTR1A BDNF
289 pervasive developmental disorder 8.8 TH SLC6A4 MAOA HTR2A HTR1A ERICD
290 autism spectrum disorder 8.7 TNF SLC6A4 MAOA HTR2A BDNF
291 constipation 8.7 TNF TH SLC6A4 HTR2A HTR1A FLNA
292 sudden infant death syndrome 8.6 TNF TH SLC6A4 MAOA HTR2A HTR1A

Graphical network of the top 20 diseases related to Neurotic Disorder:



Diseases related to Neurotic Disorder

Symptoms & Phenotypes for Neurotic Disorder

UMLS symptoms related to Neurotic Disorder:


depressed reaction, depressed - symptom

MGI Mouse Phenotypes related to Neurotic Disorder:

45 (showing 2, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 9.7 BDNF FLNA GAN GPX4 HTR1A HTR2A
2 cardiovascular system MP:0005385 9.32 DCAF8 FLNA GPX4 HTR1A MAOA MFSD8

Drugs & Therapeutics for Neurotic Disorder

Drugs for Neurotic Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 597, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Valsartan Approved, Investigational Phase 4 137862-53-4 60846
2
Ropinirole Approved, Investigational Phase 4 91374-20-8, 91374-21-9 497540 5095
3
Reboxetine Approved, Experimental Phase 4 98769-81-4, 71620-89-8 123628 65856
4
Oxcarbazepine Approved Phase 4 28721-07-5 34312
5
Parathyroid hormone Approved, Investigational Phase 4 9002-64-6
6
Brexpiprazole Approved, Investigational Phase 4 913611-97-9 11978813
7
Pioglitazone Approved, Investigational Phase 4 111025-46-8 4829
8
Amitriptyline Approved Phase 4 50-48-6 2160
9
Nitrous oxide Approved, Vet_approved Phase 4 10024-97-2 948
10
Eszopiclone Approved, Investigational Phase 4 138729-47-2 969472
11
Propranolol Approved, Investigational Phase 4 525-66-6 4946
12
Mirtazapine Approved Phase 4 85650-52-8, 61337-67-5 4205
13
Desipramine Approved, Investigational Phase 4 50-47-5 2995
14
Testosterone enanthate Approved Phase 4 315-37-7 9416
15
Testosterone undecanoate Approved, Investigational Phase 4 5949-44-0
16
Methyltestosterone Approved Phase 4 58-18-4 6010
17
Moclobemide Approved, Investigational Phase 4 71320-77-9 4235
18
Riluzole Approved, Investigational Phase 4 1744-22-5 5070
19
Memantine Approved, Investigational Phase 4 19982-08-2 4054
20
Curcumin Approved, Experimental, Investigational Phase 4 458-37-7 969516
21
Ziprasidone Approved Phase 4 146939-27-7 60854
22
Nortriptyline Approved Phase 4 72-69-5 4543
23
Iloperidone Approved Phase 4 133454-47-4 71360
24
Terazosin Approved Phase 4 63590-64-7 5401
25
Zolpidem Approved Phase 4 82626-48-0 5732
26
Calcium carbonate Approved, Investigational Phase 4 471-34-1
27
Acamprosate Approved, Investigational Phase 4 77337-76-9 71158
28
Methylphenidate Approved, Investigational Phase 4 113-45-1 4158
29
Methohexital Approved Phase 4 151-83-7 9034
30
Exenatide Approved, Investigational Phase 4 141758-74-9 15991534
31
Methadone Approved Phase 4 76-99-3 4095
32
Ribavirin Approved Phase 4 36791-04-5 37542
33
Hyaluronic acid Approved, Vet_approved Phase 4 9004-61-9 53477741
34
Medroxyprogesterone acetate Approved, Investigational Phase 4 71-58-9
35
Doxepin Approved, Investigational Phase 4 1668-19-5 667477 667468
36
Protriptyline Approved Phase 4 438-60-8 4976
37
Trimipramine Approved Phase 4 739-71-9 5584 4055
38
Topiramate Approved Phase 4 97240-79-4 5284627
39
Isocarboxazid Approved Phase 4 59-63-2 3759
40
Maprotiline Approved, Investigational Phase 4 10262-69-8 4011
41
Fluticasone Approved, Experimental Phase 4 90566-53-3 62924
42
Carbamazepine Approved, Investigational Phase 4 298-46-4 2554
43
Naloxone Approved, Vet_approved Phase 4 465-65-6 5284596
44
Donepezil Approved Phase 4 120014-06-4 3152
45
Prednisone Approved, Vet_approved Phase 4 53-03-2 5865
46
Minocycline Approved, Investigational Phase 4 10118-90-8 5281021
47
Acetylcysteine Approved, Investigational Phase 4 616-91-1 12035
48
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4 1177-87-3
49
Dexamethasone Approved, Investigational, Vet_approved Phase 4 50-02-2 5743
50
Metyrapone Approved, Investigational Phase 4 54-36-4 4174
51
Suvorexant Approved, Investigational Phase 4 1030377-33-3
52
Metformin Approved Phase 4 657-24-9 14219 4091
53
Infliximab Approved Phase 4 170277-31-3
54
Remifentanil Approved Phase 4 132875-61-7 60815
55
Alendronate Approved Phase 4 66376-36-1, 121268-17-5 2088
56
Bromocriptine Approved, Investigational Phase 4 25614-03-3 31101
57
Clonazepam Approved, Illicit Phase 4 1622-61-3 2802
58
Aripiprazole lauroxil Approved, Investigational Phase 4 1259305-29-7 49831411
59
Pregabalin Approved, Investigational Phase 4 148553-50-8 5486971
60
Guanfacine Approved, Investigational Phase 4 29110-47-2 3519
61
Milnacipran Approved, Investigational Phase 4 92623-85-3 65833
62
Levomilnacipran Approved, Investigational Phase 4 96847-54-0
63
Simvastatin Approved Phase 4 79902-63-9 54454
64
Ondansetron Approved Phase 4 99614-02-5 4595
65
Losartan Approved Phase 4 114798-26-4 3961
66
Naltrexone Approved, Investigational, Vet_approved Phase 4 16590-41-3 5360515
67
Buprenorphine Approved, Illicit, Investigational, Vet_approved Phase 4 52485-79-7 40400 644073
68
Sage Approved Phase 4
69
Propofol Approved, Investigational, Vet_approved Phase 4 2078-54-8 4943
70
Buspirone Approved, Investigational Phase 4 36505-84-7 2477
71
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4 437-38-7 3345
72
Methamphetamine Approved, Illicit Phase 4 537-46-2 10836
73
Clozapine Approved Phase 4 5786-21-0 2818
74
Levodopa Approved Phase 4 59-92-7 6047
75
Carbidopa Approved Phase 4 28860-95-9 34359